Intraperitoneal insulin via a subcutaneous peritoneal access device (SPAD) effectively managed a pregnant woman with insulin-dependent diabetes (IDDM) and insulin resistance. This innovative approach ensured excellent glycemic control and a healthy baby delivery.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: